Preparation and characterization of 2-methacryloyloxyethyl phosphorylcholine polymer nanofibers prepared via electrospinning for biomedical materials

Tomoki Maeda, Katsuya Hagiwara, Soki Yoshida, Terumitsu Hasebe, Atsushi Hotta

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Electrospun nanofibers of poly (2-methacryloyloxyethyl phosphorylcholine) (MPC) possessing excellent hemocompatibility were successfully fabricated first. These nanofibers were investigated as drug-delivery vehicles for suppressing the acute thrombogenicity of vascular grafts to lower the risk of coronary artery disease by improving the graft patency rate; the graft patency rate is the percentage of patients who do not have any blockage in a graft after a stent-graft treatment. We varied the MPC concentrations in ethanol from 1 to 10 wt % to fabricate electrospun MPC fibers. Scanning electron microscopy images revealed that when the MPC concentration was lower than 5 wt %, beads instead of fibers were formed. When the MPC concentration was increased (>5 wt %), uniform fibers were produced with average fiber diameters of about 160 nm (5 wt %), 640 nm (7.5 wt %), and 1270 nm (10 wt %). In vitro drug-release tests showed that a higher amount of drugs was diffused from MPC fibers with small diameters; this indicated a faster drug-release rate for the thinner MPC fibers. Diameter-controlled MPC fibers could be used as a new vascular graft materials. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40606.

Original languageEnglish
Article number40606
JournalJournal of Applied Polymer Science
Volume131
Issue number14
DOIs
Publication statusPublished - 2014 Jul 15

Fingerprint

Electrospinning
Nanofibers
Grafts
Polymers
Fibers
Pharmaceutical Preparations
Stents
2-methacryloyloxyethyl phosphorylcholine
Drug delivery
Ethanol
Scanning electron microscopy

Keywords

  • biomaterials
  • drug-delivery systems
  • electrospinning
  • fibers
  • phospholipids

ASJC Scopus subject areas

  • Materials Chemistry
  • Polymers and Plastics
  • Surfaces, Coatings and Films
  • Chemistry(all)

Cite this

Preparation and characterization of 2-methacryloyloxyethyl phosphorylcholine polymer nanofibers prepared via electrospinning for biomedical materials. / Maeda, Tomoki; Hagiwara, Katsuya; Yoshida, Soki; Hasebe, Terumitsu; Hotta, Atsushi.

In: Journal of Applied Polymer Science, Vol. 131, No. 14, 40606, 15.07.2014.

Research output: Contribution to journalArticle

@article{17269ef982264b08bd523b6d0c70f943,
title = "Preparation and characterization of 2-methacryloyloxyethyl phosphorylcholine polymer nanofibers prepared via electrospinning for biomedical materials",
abstract = "Electrospun nanofibers of poly (2-methacryloyloxyethyl phosphorylcholine) (MPC) possessing excellent hemocompatibility were successfully fabricated first. These nanofibers were investigated as drug-delivery vehicles for suppressing the acute thrombogenicity of vascular grafts to lower the risk of coronary artery disease by improving the graft patency rate; the graft patency rate is the percentage of patients who do not have any blockage in a graft after a stent-graft treatment. We varied the MPC concentrations in ethanol from 1 to 10 wt {\%} to fabricate electrospun MPC fibers. Scanning electron microscopy images revealed that when the MPC concentration was lower than 5 wt {\%}, beads instead of fibers were formed. When the MPC concentration was increased (>5 wt {\%}), uniform fibers were produced with average fiber diameters of about 160 nm (5 wt {\%}), 640 nm (7.5 wt {\%}), and 1270 nm (10 wt {\%}). In vitro drug-release tests showed that a higher amount of drugs was diffused from MPC fibers with small diameters; this indicated a faster drug-release rate for the thinner MPC fibers. Diameter-controlled MPC fibers could be used as a new vascular graft materials. {\circledC} 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40606.",
keywords = "biomaterials, drug-delivery systems, electrospinning, fibers, phospholipids",
author = "Tomoki Maeda and Katsuya Hagiwara and Soki Yoshida and Terumitsu Hasebe and Atsushi Hotta",
year = "2014",
month = "7",
day = "15",
doi = "10.1002/app.40606",
language = "English",
volume = "131",
journal = "Journal of Applied Polymer Science",
issn = "0021-8995",
publisher = "John Wiley and Sons Inc.",
number = "14",

}

TY - JOUR

T1 - Preparation and characterization of 2-methacryloyloxyethyl phosphorylcholine polymer nanofibers prepared via electrospinning for biomedical materials

AU - Maeda, Tomoki

AU - Hagiwara, Katsuya

AU - Yoshida, Soki

AU - Hasebe, Terumitsu

AU - Hotta, Atsushi

PY - 2014/7/15

Y1 - 2014/7/15

N2 - Electrospun nanofibers of poly (2-methacryloyloxyethyl phosphorylcholine) (MPC) possessing excellent hemocompatibility were successfully fabricated first. These nanofibers were investigated as drug-delivery vehicles for suppressing the acute thrombogenicity of vascular grafts to lower the risk of coronary artery disease by improving the graft patency rate; the graft patency rate is the percentage of patients who do not have any blockage in a graft after a stent-graft treatment. We varied the MPC concentrations in ethanol from 1 to 10 wt % to fabricate electrospun MPC fibers. Scanning electron microscopy images revealed that when the MPC concentration was lower than 5 wt %, beads instead of fibers were formed. When the MPC concentration was increased (>5 wt %), uniform fibers were produced with average fiber diameters of about 160 nm (5 wt %), 640 nm (7.5 wt %), and 1270 nm (10 wt %). In vitro drug-release tests showed that a higher amount of drugs was diffused from MPC fibers with small diameters; this indicated a faster drug-release rate for the thinner MPC fibers. Diameter-controlled MPC fibers could be used as a new vascular graft materials. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40606.

AB - Electrospun nanofibers of poly (2-methacryloyloxyethyl phosphorylcholine) (MPC) possessing excellent hemocompatibility were successfully fabricated first. These nanofibers were investigated as drug-delivery vehicles for suppressing the acute thrombogenicity of vascular grafts to lower the risk of coronary artery disease by improving the graft patency rate; the graft patency rate is the percentage of patients who do not have any blockage in a graft after a stent-graft treatment. We varied the MPC concentrations in ethanol from 1 to 10 wt % to fabricate electrospun MPC fibers. Scanning electron microscopy images revealed that when the MPC concentration was lower than 5 wt %, beads instead of fibers were formed. When the MPC concentration was increased (>5 wt %), uniform fibers were produced with average fiber diameters of about 160 nm (5 wt %), 640 nm (7.5 wt %), and 1270 nm (10 wt %). In vitro drug-release tests showed that a higher amount of drugs was diffused from MPC fibers with small diameters; this indicated a faster drug-release rate for the thinner MPC fibers. Diameter-controlled MPC fibers could be used as a new vascular graft materials. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40606.

KW - biomaterials

KW - drug-delivery systems

KW - electrospinning

KW - fibers

KW - phospholipids

UR - http://www.scopus.com/inward/record.url?scp=84899452911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899452911&partnerID=8YFLogxK

U2 - 10.1002/app.40606

DO - 10.1002/app.40606

M3 - Article

VL - 131

JO - Journal of Applied Polymer Science

JF - Journal of Applied Polymer Science

SN - 0021-8995

IS - 14

M1 - 40606

ER -